Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FMISO”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Not applicableEnded earlyNCT01617980
What this trial is testing

Multimodal Hypoxia Imaging and Intensity Modulated Radiotherapy for Inoperable Non-small-cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
German Cancer Research Center 4
Testing effectiveness (Phase 2)Study completedNCT01213030
What this trial is testing

Clinical Evaluation of the New Hypoxia Imaging Agent HX4

Who this might be right for
Head and Neck CancerLung CancerLiver Cancer
Siemens Molecular Imaging 12
Very early researchStudy completedNCT05250895
What this trial is testing

BOLD MRI and FMISO PET for the Assessment of Hypoxic Tumor Microenvironment in Patients with Oligometastatic Liver Cancer Undergoing Yttirum-90 Selective Internal Radiation Therapy

Who this might be right for
BCLC Stage a Hepatocellular CarcinomaBCLC Stage B Hepatocellular CarcinomaBCLC Stage C Hepatocellular Carcinoma+1 more
Emory University 9
Not applicableStudy completedNCT01235052
What this trial is testing

Prognostic Evaluation of 18fmiso Pet-ct in Head and Neck Cancer

Who this might be right for
Cancer of Head and NeckHead and Neck Neoplasms
University Hospital, Bordeaux 16
Not applicableUnknownNCT01330186
What this trial is testing

Predictive Value of FMISO-PET, FDG-PET-CT, DWI-MRI and DCE-MRI Scans for Patients With Anal Cancer Receiving Radiotherapy +/- Chemotherapy

Who this might be right for
Anal Cancer
Copenhagen University Hospital at Herlev 50
Testing effectiveness (Phase 2)Study completedNCT00902577
What this trial is testing

MRI and PET/FMISO In Assessing Tumor Hypoxia in Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Study completedNCT00559377
What this trial is testing

FDG and FMISO PET Hypoxia Evaluation in Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Squamous Cell CarcinomaStage IB Cervical Cancer+5 more
National Cancer Institute (NCI) 16
Testing effectiveness (Phase 2)Study completedNCT00906893
What this trial is testing

Evaluation of [18F]-FMISO for Non Operated Glioblastoma

Who this might be right for
Glioblastoma
University Hospital, Bordeaux 14
Testing effectiveness (Phase 2)Looking for participantsNCT06087614
What this trial is testing

Dose Escalation Using Hypoxia-adjusted Radiotherapy

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Rajiv Gandhi Cancer Institute & Research Center, India 124
Not applicableWithdrawnNCT00038038
What this trial is testing

Assessment of Head and Neck Tumor Hypoxia Using 18F-Fluoromisonidazole

Who this might be right for
Squamous Cell CarcinomaHead and Neck NeoplasmsMetastases, Neoplasm
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01898065
What this trial is testing

Evaluation of Hypoxia by PET With F-Miso in Radiation Therapy of Prostate Cancer

Who this might be right for
Prostate Adenocarcinoma
Institut Cancerologie de l'Ouest 20
Early research (Phase 1)Ended earlyNCT01246869
What this trial is testing

Assessment of Primary and Metastatic Brain Tumor Hypoxia With Fluoromisonidazole, FDG and Water

Who this might be right for
Brain Cancer
University of Utah 2
Testing effectiveness (Phase 2)UnknownNCT01576796
What this trial is testing

Radiotherapy Dose Complement in the Treatment of Hypoxic Lesions Patients With Stage III Non-small-cell Lung Cancer

Who this might be right for
Stage III Non-small-cell Lung Cancer
Centre Henri Becquerel 75
Not applicableLooking for participantsNCT06307015
What this trial is testing

De-escalation of Radiation Dose in HPV-associated OPC Utilising FMISO PET (DE-RADIATE)

Who this might be right for
HPV Positive Oropharyngeal Squamous Cell Carcinoma
Royal North Shore Hospital 25
Not applicableStudy completedNCT04995185
What this trial is testing

18F-FMISO PET Guided Dose Escalation in Nasopharyngeal Carcinoma - a Feasibility and Planning Study

Who this might be right for
Nasopharyngeal Carcinoma
National Cancer Centre, Singapore 9
Not applicableStudy completedNCT00713037
What this trial is testing

Hypoxia-positron Emission Tomography (PET) and Intensity Modulated Proton Therapy (IMPT) Dose Painting in Patients With Chordomas

Who this might be right for
Chordoma
Massachusetts General Hospital 20
Not applicableStudy completedNCT06027021
What this trial is testing

Assessment of Hypoxia Before Radioembolization Treatment With 18F-FMISO PET

Who this might be right for
RadioembolizationRadiotherapyCancer+1 more
Ankara University 64
Early research (Phase 1)Ended earlyNCT03573986
What this trial is testing

Pilot Study of 18F-FMISO PET/CT and MRI Imaging to Explore Tissue Hypoxia and Arteriovenous Shunting in Subjects With Recurrent Glioblastoma Before and After Bevacizumab Treatment

Who this might be right for
Recurrent Glioblastoma
Abramson Cancer Center at Penn Medicine 2
Not applicableStudy completedNCT00180180
What this trial is testing

Tumor Hypoxia of Head-and-neck Cancer Underwent Radiation Therapy Measured With F-18-FMISO

Who this might be right for
Head and Neck Neoplasms
Technische Universität Dresden 60
Testing effectiveness (Phase 2)Ended earlyNCT01868906
What this trial is testing

FMISO-PET in Brain Tumors and SCS Effect

Who this might be right for
Malignant Glioma
Bernardino Clavo, MD, PhD 6
Next Page